ArticleScience translational medicine2018

Exploiting an Asp-Glu "switch" in glycogen synthase kinase 3 to design paralog-selective inhibitors for use in acute myeloid leukemia.

Florence F Wagner et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.